BioRestorative Therapies Inc (BRTX) Stock Analysis

BioRestorative Therapies Inc (BRTX) is a publicly traded company in the HEALTHCARE sector. It trades at $0.35, carries a market capitalization of $10.35M. This page summarizes the public market data, fundamentals, and frequently asked questions for BRTX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.35
• Market Cap: $10.35M
• EPS: $-1.06
• 52-Week High: $2.04
• 52-Week Low: $0.16

Market Sentiment

BioRestorative Therapies Inc currently has a Bullish sentiment score of 0.15.

About BioRestorative Therapies Inc

BioRestorative Therapies Inc. (BRTX) is a pioneering life sciences company headquartered in Melville, New York, focused on advancing regenerative medicine through innovative therapies utilizing adult stem cell technology. The company is dedicated to addressing critical unmet medical needs by developing safe and effective treatments grounded in cellular and tissue-based methodologies. With a strategic emphasis on orthopedics, neurology, and other therapeutic areas, BioRestorative Therapies is ...

GNG Research Analysis

GNG Research scores BioRestorative Therapies Inc (BRTX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BRTX.

Frequently Asked Questions

Does BRTX pay dividends?

BioRestorative Therapies Inc (BRTX) does not currently pay a regular dividend.

What is BRTX's market cap?

BioRestorative Therapies Inc (BRTX) has a market capitalization of $10.35M with a current stock price of $0.35.